Table 3.
The number of participants in each risk group according to Cariogram, at baseline and at follow-up.
| DMFT/DMFS | 0–20% (Group 1) | 21–40% (Group 2) | 41–60% (Group 3) | 61–80% (Group 4) | 81–100% (Group 5) |
|---|---|---|---|---|---|
| Number of individuals | |||||
|
| |||||
| At baseline (%) | 13 | 20 | 33 | 24 | 10 |
| At follow-up (%) | 15 | 26 | 32 | 20 | 7 |
| Mean DMFT at baseline | 10.87±5.05 | 7.15±3.99 | 8.43±3.93 | 6.39±3.25 | 3.86±2.97 |
| Mean DMFT at follow-up | 12.1±5.15 | 7.8±3.8 | 8.82±3.96 | 6.47±3.29 | 3.86±2.97 |
| Mean DMFT increment | 1.23±0.86 | 0.65±0.81 | 0.39±1.02 | 0.08±0.28 | 0 |
| Mean DMFS increment | 1.23±0.86 | 0.9±0.97 | 0.48±1.06 | 0.08±0.28 | 0 |
| Mean number of new developed carious lesion | 1.23±0.86a | 0.9±0.97a | 0.48±1.06b | 0.08±0.28b | 0b |
*
Different letters in the same line indicate significant differences between the different categories of Cariogram.